'War on Cancer' success examined

Share this article:
'War on Cancer' Has Made Progress
'War on Cancer' Has Made Progress

FRIDAY, Jan. 24, 2014 (HealthDay News) -- More people are being diagnosed with and dying from cancer, but this is largely the result of declines in mortality from other causes, according to a study published online Jan. 13 in the Journal of Clinical Oncology.

Samir Soneji, Ph.D., from the Geisel School of Medicine at Dartmouth in Hanover, N.H., and colleagues utilized data from the Surveillance, Epidemiology, and End Results registries to identify annual breast, colorectal, lung, and prostate cancer mortality rates. National death certificates from 1975 to 2005 were used to assess noncancer mortality rates.

The researchers found that declining cancer mortality rates reduced the burden of mortality from leading cancers, but this progress was offset by cancer incidence increases as a result of decreasing other-cause mortality rates. For instance, the burden of lung cancer in males declined by 0.1 year of life lost between 1985 to 1989 and 2000 to 2004. Two factors contributed to this decline: decreasing lung cancer mortality rates that reduced the average burden of lung cancer mortality by 0.33 years of life lost and declining other-cause mortality rates that raised it by 0.23 years. Similar patterns were seen with other common cancers.

"By using a measure that accounts for increased cancer incidence as a result of improvements in cardiovascular disease mortality, we find that prior assessments have underestimated the impact of cancer interventions," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Meta-Analysis: Prediabetes tied to increased risk of cancer

Meta-Analysis: Prediabetes tied to increased risk of cancer

Prediabetes has been linked to an increased risk of cancer overall and with increased risks of site-specific cancers, including liver, endometrial, and stomach/colorectal cancer.

Joint ASCO/CCO guidelines for advanced prostate cancer issued

Joint ASCO/CCO guidelines for advanced prostate cancer issued

Recommendations are for men whose tumors have grown resistant to hormonal therapies were issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada.

Health care spending rise expected over next decade

Health care spending rise expected over next decade

Insurance coverage under ACA, population aging, and economic growth will likely drive future spending increases.